Skip to main navigation Skip to search Skip to main content

A Randomized, Open-Label, Long-Term, Parallel-Group, Comparator-Controlled, Multicenter Study to Compare the Glycemic Effects, Safety and Tolerability of Exanatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects with Type 2 Di

Project: Research

Project Details

StatusFinished
Effective start/end date01/8/13 → 06/15/15

Funding

  • Medpace Inc: $18,357.87